| Magnetic-Fluorescent Nano-Beads |
|
This invention implements a new method of simultaneous detection and separation of biological entities like specific cells, based on magnetic nanobeads of strictly controlled size. The nanobeads can be used in a number of biomedical applications, such as bioimaging, bio- and chemo-sensing, cell tracking and sorting, bioseparation, drug delivery and therapy systems in nanomedicine, etc.
The nanobeads are made of aggregates of iron oxide nanoparticles (IONPs) enwrapped within an amphiphillic polymer (Pc18) to which oligothiophene fluorescents (OTFs) are grafted; their size is selectable in the range 30 to 400 nm. Additionally, the nanobeads are functionalized with a variety of molecules for detecting specific bio-targets and are easily dispersible in the interaction medium with cells or markers; therefore these nanobeads can be used in a number of biomedical applications, such as bioimaging, bio- and chemo-sensing, cell tracking and sorting, bioseparation, drug delivery and therapy systems in nanomedicine, etc.
The fabrication process does not require separate steps of clustering iron oxide nanoparticles and of fluorescent coating of these clusters, with the associated difficulties of selection and separation, but a precise size with narrow dispersion of the complete nanobeads is achieved in a single step by easy control of the fabrication parameters. These include the shaking speed at which the polymer and the IONPs are mixed in a first solvent, the rate at which a solvent of different polarity is added to the prepared mixture, and the polarity of solvents. The nanobeads are highly photostable, as the OTFs are shielded by the Pc18 shell, have low toxicity, are fuorescence tunable due to the OTFs properties, can be easily conjugated to a variety of molecules to detect specifc bio-targets, and respond quickly to a magnetic field. Patent Application No. TO2009A000169 Contact: Technology Transfer Tel: +39 010 71781569 +39 010 71781568 Fax: +39 010 7170187 This e-mail address is being protected from spambots. You need JavaScript enabled to view it |

